1. Search Result
Search Result
Results for "

ENZ

" in MedChemExpress (MCE) Product Catalog:

54

Inhibitors & Agonists

1

Screening Libraries

1

MCE Kits

2

Inhibitory Antibodies

1

Natural
Products

163

Recombinant Proteins

4

Isotope-Labeled Compounds

80

Antibodies

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-70002
    Enzalutamide
    Maximum Cited Publications
    214 Publications Verification

    MDV3100

    Androgen Receptor Autophagy Cancer
    Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells. Enzalutamide is an autophagy activator .
    Enzalutamide
  • HY-10342
    Enzastaurin
    10+ Cited Publications

    LY317615

    PKC Autophagy Apoptosis Neurological Disease Inflammation/Immunology Cancer
    Enzastaurin (LY317615) is a potent, selective, and CNS-penetrant PKCβ inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKCα, PKCγ and PKCε .
    Enzastaurin
  • HY-124861
    Malic enzyme inhibitor ME1
    5 Publications Verification

    ME1

    Fatty Acid Synthase (FASN) Metabolic Disease Cancer
    Malic enzyme inhibitor ME1 (ME1; compound 1) is a potent inhibitor of Malic enzyme (ME1) with an IC50 of 0.15 μM .
    Malic enzyme inhibitor ME1
  • HY-156794

    DSP-5336

    Epigenetic Reader Domain FLT3 Cancer
    Enzomenib (DSP-5336) is an orally active Menin inhibitor (IC50=1.4 nM, Kd=6.0 nM). Enzomenib disrupts the interaction between Menin and KMT2A/MLL fusion proteins, specifically inhibits the expression of leukemia driver genes such as HOX/MEIS1, and upregulates ITGAM. Enzomenib effectively induces cell differentiation, inhibits tumor cell proliferation, and suppresses primitive cell colony formation. Enzomenib reduces disease burden and prolongs survival, but causes adverse reactions including differentiation syndrome and QTc interval prolongation. Enzomenib is used for research on relapsed/refractory acute myeloid leukemia, acute lymphoblastic leukemia, and other hematologic malignancies with mixed lineage leukemia (MLL) rearrangements or NPM1 mutations .
    Enzomenib
  • HY-70002R

    MDV3100 (Standard)

    Reference Standards Androgen Receptor Autophagy Cancer
    Enzalutamide (Standard) is the analytical standard of Enzalutamide. This product is intended for research and analytical applications. Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells. Enzalutamide is an autophagy activator .
    Enzalutamide (Standard)
  • HY-70002B
    Enzalutamide carboxylic acid
    2 Publications Verification

    MDV3100 carboxylic acid

    Drug Metabolite Cancer
    Enzalutamide carboxylic acid (MDV3100 carboxylic acid) is an inactive metabolite of Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist .
    Enzalutamide carboxylic acid
  • HY-70002A
    N-Desmethyl enzalutamide
    1 Publications Verification

    N-Desmethyl MDV 3100

    Androgen Receptor Cancer
    N-desmethyl Enzalutamide is the active metabolite of Enzalutamide.N-desmethyl Enzalutamide is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar potency to Enzalutamide and circulates at approximately the same plasma concentrations as enzalutamide .
    N-Desmethyl enzalutamide
  • HY-70002S1

    MDV3100-d6

    Isotope-Labeled Compounds Androgen Receptor Cancer
    Enzalutamide-d6 (MDV3100-d6) is a deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells .
    Enzalutamide-d6
  • HY-P3173

    R-ENZyme

    Biochemical Assay Reagents Others
    Pullulanase (R-enzyme) is a key starch debranching enzyme that specifically hydrolyzes α-1,6-glycosidic linkages in polysaccharides such as amylopectin and pullulan, facilitating the efficient degradation of starch into fermentable sugars .
    Pullulanase
  • HY-17587
    4-Methylbenzylidene camphor
    2 Publications Verification

    4-MBC; ENZacamene

    Apoptosis PI3K Akt ERK Metabolic Disease
    4-Methylbenzylidene camphor (4-MBC) is an endocrine disrupter that produces estrogen-like effects. 4-Methylbenzylidene camphor decreases the proliferation of human trophoblast cells and induces apoptosis. 4-Methylbenzylidene camphor activates PI3K/AKT and ERK1/2 signaling pathways and elevates intracellular ROS production. 4-Methylbenzylidene camphor is a ultraviolet (UV) filter and may hamper normal placental formation during early pregnancy .
    4-Methylbenzylidene camphor
  • HY-70002S

    ENZalutamide-d3; MDV3100-d3

    Androgen Receptor Autophagy Cancer
    Deutenzalutamide (Enzalutamide-d3) is a developed deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells .
    Deutenzalutamide
  • HY-E70600

    Carboxylesterase (CES) Others
    Human CES1 Enzyme is a recombinantly expressed CES1 enzyme. Human CES1 Enzyme, an enzyme responsible for the hydrolysis of ester- and amide-containing molecules, is mainly expressed in the liver where it is crucial for the processing of active metabolites and is also involved in trans-esterification reactions .
    Human CES1 Enzyme
  • HY-P2983

    Kininase II; CD143

    Endogenous Metabolite Cardiovascular Disease Cancer
    Angiotensin-converting enzyme (Kininase II) is a dicarboxypeptidase, it converts inactive Angiotensin I (Ang I) to active Ang II and degrades active bradykinin (BK). Angiotensin-converting enzyme is a potent vasoconstrictor, is often used in biochemical studies .
    Angiotensin-converting enzyme
  • HY-E70333

    AR2000

    Endogenous Metabolite Others
    Microgranulated pectolytic enzyme is a biocatalyst and a key enzyme in new biocatalyst technology. Enzyme engineering focuses on enhancing enzyme reaction kinetics, substrate selectivity, and activity under harsh conditions such as low or high pH. By introducing stimulus responsiveness to these enzyme modifications, dynamic control of activity is also possible .
    Microgranulated pectolytic enzyme
  • HY-150226

    Proteasome Inflammation/Immunology
    Enzyme-IN-1 (compound 1) is a peptide-based inhibitor of N-terminal nucleophile (Ntn) hydrolases. Specifically, Enzyme-IN-1 inhibits the chymotrypsin-like activity (CT-L) of the 20S proteasome. Enzyme-IN-1 may has potential antiinflammatory properties .
    Enzyme-IN-1
  • HY-E70231

    Others Cardiovascular Disease
    Thrombin-like enzyme is a proteolytic enzyme extraction of Agkistrodon halys venom. Thrombin-like enzyme can be used for degradation of fibrinogen. Thrombin-like enzyme can exacerbate myosin-induced EAM (experimental autoimmune myositis). Thrombin-like enzyme can be used for degradation of fibrinogen. Thrombin-like enzyme is commonly used for research of acute ischemic cerebrovascular disease, thromboangiitis obliterans, deep phlebitis and sudden deafness .
    Thrombin-like enzyme
  • HY-70002AS

    N-Desmethyl MDV 3100-d6

    Androgen Receptor Cancer
    N-desmethyl Enzalutamide-d6 is a deuterium labeled N-desmethyl Enzalutamide. N-desmethyl Enzalutamide is an active metabolite of Enzalutamide. N-desmethyl Enzalutamide is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar potency to Enzalutamide and circulates at approximately the same plasma concentrations as enzalutamide .
    N-Desmethyl enzalutamide-d6
  • HY-109004

    BTA-C585

    RSV Infection
    Enzaplatovir (BTA-C585) is an orally bioavailable Inhibitor for respiratory syncytial virus (RSV) infection .
    Enzaplatovir
  • HY-E70599

    Carboxylesterase (CES) Metabolic Disease
    Human CES2 Enzyme is a carboxylesterase involved in drug metabolism and lipid homeostasis. Human CES2 Enzyme hydrolyzes triglycerides, cholesteryl esters and retinyl esters to regulate lipid metabolism and energy homeostasis. Human CES2 Enzyme improves glucose tolerance and insulin sensitivity, reduces hepatic lipid accumulation, alleviates white adipose tissue steatitis, decreases plasma cholesterol levels, and reduces body weight and white adipose tissue weight. Human CES2 Enzyme can be used in the research of metabolic syndrome .
    Human CES2 Enzyme
  • HY-146177

    Bacterial Cytochrome P450 Infection
    CYP3A4 enzyme-IN-1 (compound 59) is a potent antibacterial agent, with a MIC of 1 μg/mL for MRSA. CYP3A4 enzyme-IN-1 exhibits low to moderate inhibitory effects on CYP1A2, CYP2E1, CYP2D6, and CYP3A4 enzymes .
    CYP3A4 enzyme-IN-1
  • HY-P991135

    RO-7502175; RG-6411

    CCR Cancer
    Enzelkitug is a humanized immunoglobulin G1-κ monoclonal antibody targeting the human C-C motif chemokine receptor 8 (CCR8). Enzelkitug is promising for research of various solid tumors and hematological malignancies .
    Enzelkitug
  • HY-10539B

    LY317615 hydrochloride

    PKC Autophagy Apoptosis Cancer
    Enzastaurin (LY317615) hydrochloride is a potent and selective PKCβ inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKCα, PKCγ and PKCε .
    Enzastaurin hydrochloride
  • HY-155521

    Bacterial Infection
    Enzyme-IN-2 (compound 15) is a ureases inhibitor (Ki=2.36 μM) with anti-ureolytic activity (IC50=0.75 μM) .
    Enzyme-IN-2
  • HY-138870

    Bacterial Infection
    Enzyme-IN-3 disodium (compound 7) is a selective inhibitor of Mycobacterium tuberculosis shikimate kinase with an IC50 of 1.6 μM. Enzyme-IN-3 disodium has antibacterial activity .
    Enzyme-IN-3 disodium
  • HY-E70391

    Others Others
    C1r Enzyme is the activated form of the C1r zymogen and serves as an activator of Cls .
    C1r Enzyme
  • HY-Z3770

    Drug Intermediate Others
    Enzalutamide impurity 4 is an impurity of Enzalutamide (HY-70002).
    Enzalutamide impurity 4
  • HY-E70560

    Biochemical Assay Reagents Others
    Cellular digestive enzyme is often used as an alternative to trypsin for detaching adherent cells from a culture dish .
    Cellular digestive enzyme
  • HY-109004A

    (S)-BTA-C585

    RSV Cancer
    (S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77) .
    (S)-Enzaplatovir
  • HY-10539

    LY317615 dihydrochloride

    PKC Autophagy Apoptosis Cancer
    Enzastaurin (LY317615) dihydrochloride is a potent and selective PKCβ inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKCα, PKCγ and PKCε .
    Enzastaurin dihydrochloride
  • HY-10342R

    LY317615 (Standard)

    Reference Standards PKC Autophagy Apoptosis Cancer
    Enzastaurin (Standard) is the analytical standard of Enzastaurin. This product is intended for research and analytical applications. Enzastaurin (LY317615) is a potent and selective PKCβ inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKCα, PKCγ and PKCε .
    Enzastaurin (Standard)
  • HY-E70390

    masp-2, c1 esterase, c1-esterase

    Wnt Cardiovascular Disease Inflammation/Immunology
    C1s Enzyme is a subunit of the complement C1 complex, which activates the complement as a serine protease. C1s Enzyme cleaves LRP5 and LRP6, and thus activates the Wnt/β-Catenin signaling pathway. C1s Enzyme promotes the macrophage M2 polarization and inhibits M1 polarization. C1s Enzyme enhances efferocytosis, exhibits anti-inflammatory activity .
    C1s Enzyme
  • HY-E70080

    Biochemical Assay Reagents Others
    Vaccinia virus capping enzyme is a transcription initiation factor. Vaccinia virus capping enzyme is a heterodimer of D1 (844 aa) and D12 (287 aa) polypeptides that executes all three steps in m7GpppRNA synthesis. Vaccinia virus capping enzyme has been used widely as a reagent for capping and cap-labeling RNAs in vitro .
    Vaccinia virus capping enzyme
  • HY-E70618

    E1/E2/E3 Enzyme Cancer
    Ubiquitin Conjugating enzyme E2C (EC 2.3.2.24) is a member of the E2 ubiquitin-conjugating enzyme family, and it is the principal regulator of pathways for protein degradation in eukaryotes. Ubiquitin Conjugating enzyme E2C is involved in the tumorigenesis of various malignancies. Ubiquitin Conjugating enzyme E2C is also involved in mitotic cyclin disruption, affecting cell cycle progression. Ubiquitin Conjugating enzyme E2C is a prognostic indicator for cholangiocarcinoma .
    Ubiquitin Conjugating enzyme E2C
  • HY-70002BS

    MDV3100 carboxylic acid-d6

    Autophagy Androgen Receptor Isotope-Labeled Compounds Cancer
    Enzalutamide carboxylic acid-d6 is the deuterium labeled Enzalutamide carboxylic acid (MDV3100 carboxylic acid). Enzalutamide carboxylic acid is an inactive metabolite of Enzalutamide .
    Enzalutamide carboxylic acid-d6
  • HY-70002BR

    MDV3100 carboxylic acid (Standard)

    Reference Standards Drug Metabolite Cancer
    Bromoxynil octanoate (Standard) is the analytical standard of Bromoxynil octanoate. This product is intended for research and analytical applications. Bromoxynil octanoate is an herbicide widely applied to maize, is potentially toxic to both animals and humans .
    Enzalutamide carboxylic acid (Standard)
  • HY-70002AR

    N-Desmethyl MDV 3100 (Standard)

    Androgen Receptor Reference Standards Cancer
    N-desmethyl Enzalutamide (Standard) is the analytical standard of N-desmethyl Enzalutamide. This product is intended for research and analytical applications. N-desmethyl Enzalutamide is the active metabolite of Enzalutamide.N-desmethyl Enzalutamide is the active metabolite of Enzalutamide. N-desmethyl Enzalutamide demonstrates primary and secondary pharmacodynamics of similar potency to Enzalutamide and circulates at approximately the same plasma concentrations as enzalutamide .
    N-Desmethyl enzalutamide (Standard)
  • HY-17587R

    4-MBC (Standard); ENZacamene (Standard)

    Reference Standards Apoptosis PI3K Akt ERK Metabolic Disease
    4-Methylbenzylidene camphor (Standard) is the analytical standard of 4-Methylbenzylidene camphor. This product is intended for research and analytical applications. 4-Methylbenzylidene camphor (4-MBC) is an endocrine disrupter that produces estrogen-like effects. 4-Methylbenzylidene camphor decreases the proliferation of human trophoblast cells and induces apoptosis. 4-Methylbenzylidene camphor activates PI3K/AKT and ERK1/2 signaling pathways and elevates intracellular ROS production. 4-Methylbenzylidene camphor is a ultraviolet (UV) filter and may hamper normal placental formation during early pregnancy .
    4-Methylbenzylidene camphor (Standard)
  • HY-E70399

    5-Formiminotetrahydrofolate:L-glutamate N-formiminotransferase, FIGLU ENZymes; glutamate formimidoyltransferase

    Biochemical Assay Reagents Others
    Formimino-L-glutamic acid Transferase can convert aminomethyleneglutamic acid FIGLU and tetrahydrofolate THF into L-glutamic acid and 5-formimino-THF .
    Formimino-L-glutamic acid Transferase, porcine liver
  • HY-W842446

    Glyoxalase (GLO) Infection
    Enzyme-IN-4 is a competitive inhibitor of glyoxalase I that can be found in Stereum hirsutum. Enzyme-IN-4 has a Ki value of 4.6 μM against rat liver glyoxalase I .
    Enzyme-IN-4
  • HY-W834690

    Phosphatase Metabolic Disease
    G6Pase catalytic enzyme-IN-1 is a competitive inhibitor of glucose-6-phosphatase catalytic enzyme. G6Pase catalytic enzyme-IN-1 has an IC50 of 10 μM in pig liver microsomes. G6Pase catalytic enzyme-IN-1 can be used in studies related to type 2 diabetes .
    G6Pase catalytic enzyme-IN-1
  • HY-P2983C

    Endogenous Metabolite Metabolic Disease
    Angiotensin Converting Enzyme, Bovine (EC 3.4.15.1) increases blood pressure by causing blood vessels to constrict. Angiotensin Converting Enzyme, Bovine (EC 3.4.15.1) does that by converting angiotensin I to angiotensin II, which constricts the vessels.
    Angiotensin Converting Enzyme, Bovine
  • HY-P2983B

    Angiotensin-converting Enzyme (ACE) Cardiovascular Disease
    Angiotensin Converting Enzyme, Rabbit (EC 3.4.15.1) indirectly increases blood pressure by causing blood vessels to constrict. Angiotensin Converting Enzyme does that by converting angiotensin I to angiotensin II, which constricts the vessels.
    Angiotensin Converting Enzyme, Rabbit
  • HY-P2983A

    Angiotensin-converting Enzyme (ACE) Cardiovascular Disease
    Angiotensin Converting Enzyme, Rat (EC 3.4.15.1) indirectly increases blood pressure by causing blood vessels to constrict. Angiotensin Converting Enzyme does that by converting angiotensin I to angiotensin II, which constricts the vessels.
    Angiotensin Converting Enzyme, Rat
  • HY-E71055B

    Glycogen branching enzyme, Escherichia coli
  • HY-E71055

    Glycogen branching enzyme, Bacillus subtilis
  • HY-E71055A

    Glycogen branching enzyme, Bacteroides fragilis
  • HY-E70953

    Pyruvate Kinase Lactate Dehydrogenase Metabolic Disease
    Pyruvate Kinase/Lactic Dehydrogenase enzymes, Rabbit catalyzes an ATP-dependent phosphorylation of glycolate to yield 2-phosphoglycolate. Pyruvate kinase requires bivalent and monovalent cations such as Mg 2+ and K + respectively for activation to occur.
    Pyruvate Kinase/Lactic Dehydrogenase enzymes, Rabbit
  • HY-156794A

    DSP-5336 enantiomer

    Drug Isomer FLT3 Epigenetic Reader Domain Cardiovascular Disease Cancer
    Enzomenib enantiomer (DSP-5336 enantiomer) is an enantiomer of Enzomenib (HY-156794). Enzomenib (DSP-5336) is an orally active Menin inhibitor (IC50=1.4 nM, Kd=6.0 nM). Enzomenib disrupts the interaction between Menin and KMT2A/MLL fusion proteins, specifically inhibits the expression of leukemia driver genes such as HOX/MEIS1, and upregulates ITGAM. Enzomenib effectively induces cell differentiation, inhibits tumor cell proliferation, and suppresses primitive cell colony formation. Enzomenib reduces disease burden and prolongs survival, but causes adverse reactions including differentiation syndrome and QTc interval prolongation. Enzomenib is used for research on relapsed/refractory acute myeloid leukemia, acute lymphoblastic leukemia, and other hematologic malignancies with mixed lineage leukemia (MLL) rearrangements or NPM1 mutations .
    Enzomenib enantiomer
  • HY-Z3770R

    Reference Standards
    methyl 2-fluoro-4-((1-methoxy-2-methyl-1-oxopropan-2-yl)amino)benzoate (Enzalutamide Impurity) (Standard) is the analytical standard of methyl 2-fluoro-4-((1-methoxy-2-methyl-1-oxopropan-2-yl)amino)benzoate (Enzalutamide Impurity). This product is intended for research and analytical applications.
    Enzalutamide impurity 4 (Standard)
  • HY-109004R

    BTA-C585 (Standard)

    Reference Standards RSV Infection
    Enzaplatovir (Standard) is the analytical standard of Enzaplatovir (HY-109004). This product is intended for research and analytical applications. Enzaplatovir (BTA-C585) is an orally bioavailable Inhibitor for respiratory syncytial virus (RSV) infection .
    Enzaplatovir (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: